Recombinant Bovine Somatotropin vs High-Fructose Corn Syrup: which is worse?

What is Recombinant Bovine Somatotropin?

Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.

What is High-Fructose Corn Syrup?

High-fructose corn syrup (HFCS) is a liquid sweetener produced by enzymatically converting a portion of corn syrup's glucose to fructose. The most common forms are HFCS-55 (55% fructose, 45% glucose, used primarily in beverages) and HFCS-42 (42% fructose, used in processed foods). It became dominant in the US food supply in the 1970s-1980s.

Documented risks

Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.

High-Fructose Corn Syrup: HFCS has been at the center of one of nutrition science's most contentious debates for 30+ years. The core concern is that fructose is metabolized differently than glucose: fructose is processed primarily in the liver where it can be converted to fat (de novo lipogenesis), contributing to non-alcoholic fatty liver disease (NAFLD) and elevated triglycerides. A landmark 2004 paper by Bray, Nielsen, and Popkin in the American Journal of Clinical Nutrition proposed that the increase in HFCS consumption from the 1970s tracked with rising obesity rates. This hypothesis was widely publicized but contested; subsequent controlled research found that HFCS and sucrose produce similar metabolic effects calorie-for-calorie. However, the broader research on fructose metabolism supports metabolic concerns. A 2012 PLOS ONE study (Basu et al.) found higher sugar-sweetened beverage consumption associated with increased rates of metabolic syndrome and type 2 diabetes. A 2012 Nature commentary by Lustig, Schmidt, and Brindis ('The Toxic Truth About Sugar') argued fructose's hepatic metabolism makes it uniquely harmful — prompting significant scientific debate. Key established effects of high fructose intake include: increased visceral fat, elevated blood triglycerides, increased uric acid (gout risk), worsened insulin resistance, and accelerated NAFLD progression. These effects occur with high fructose intake from any source (HFCS or sucrose), making HFCS no inherently worse than sucrose at equivalent doses — but its ubiquity in US processed foods contributes to chronically elevated fructose exposure at a population level. Mercury contamination: in 2009, independent testing by the Institute for Agriculture and Trade Policy (IATP) and a study in Environmental Health found mercury traces in some HFCS samples from certain manufacturers using mercury-grade caustic soda. The industry has largely transitioned to mercury-free processing since these findings.